NCT04146558

Brief Summary

Psoriasis is a chronic, immune-mediated inflammatory skin disease that is associated with substantial impairment of physical and psychological quality of life. The conventional treatment protocols manages the condition but with remissions and relapses which create anxiety in patients. Many of the patients withdraw from active social life as the disease attains chronicity. Several studies are pointing towards a conjoint management strategy incorporating the traditional and alternate medical systems. In this regard, Ayurveda is commonly used by psoriatic patients in India. Considering this fact it is high time to conduct a study to scientifically evaluate the efficacy of Ayurvedic treatment protocol in managing psoriasis as well as its potential to improve the quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Dec 2019

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 31, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

December 4, 2019

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

June 15, 2025

Status Verified

June 1, 2025

Enrollment Period

3.6 years

First QC Date

October 29, 2019

Last Update Submit

June 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Psoriasis-specific quality of life

    Psoriasis specific DLQI scores

    6 months

Secondary Outcomes (8)

  • Psoriasis Severity

    3 months

  • Psoriasis Severity

    6 months

  • Psoriasis Severity

    12 months

  • Psoriasis-specific quality of life

    3 months

  • Psoriasis-specific quality of life

    12 months

  • +3 more secondary outcomes

Study Arms (2)

Internal ayurvedic treatment

EXPERIMENTAL

All possible internal preparations will be administered for a period of 12 months. All administered preparations with its dosage and duration will be documented All preparations will be subjected to lab test for clearing heavy metal and pesticide content before the administration

Drug: Individualized internal ayurvedic treatment

External ayurvedic treatment

ACTIVE COMPARATOR

Application of warm external oil (Ayyapala kera tailam) on affected parts twice daily

Other: External ayurvedic treatment

Interventions

All possible internal preparations will be administered for a period of 12 months. All administered preparations with its dosage and duration will be documented All preparations will be subjected to lab test for clearing heavy metal and pesticide content before the administration

Internal ayurvedic treatment

Application of warm external oil (Ayyapala kera tailam) on affected parts twice daily

External ayurvedic treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with psoriasis having age 18 years or more
  • Patients with moderate-to-severe plaque psoriasis with a PASI score of 12 or higher
  • Psoriasis diagnosed 6 months or more before study entry
  • Those who are poorly controlled based on physicians assessment with topical treatments, phototherapy, systemic therapy, or a combination of these therapies.
  • Participants who have given informed consent.

You may not qualify if:

  • Participants with other systemic illnesses
  • Lactating and pregnant mothers.
  • Alcohol dependence/Narcotic dependence /Steroid dependence
  • In the judgment of the investigator, unable or unwilling to follow the protocol and instructions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PNNM Ayurveda College

Shōranūr, Kerala, 679 531, India

Location

MeSH Terms

Conditions

Psoriasis

Condition Hierarchy (Ancestors)

Skin Diseases, PapulosquamousSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 29, 2019

First Posted

October 31, 2019

Study Start

December 4, 2019

Primary Completion

June 30, 2023

Study Completion

December 31, 2023

Last Updated

June 15, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations